Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-005913

CVP, Chief Financial Officer acquired 9,450 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-11 Grant or award : show line 1 in the form +9,450 27,744 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-11 Grant or award : show line 2 in the form Employee Stock Option (Right to Acquire) +72,900 $88.78 2030-05-10 72,900 72,900 D
2023-05-11 Grant or award : show line 3 in the form Performance Rights +11,825 11,825 11,825 D
Loading xslF345X04/doc4.xml…